medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2021, Number 01

<< Back Next >>

Ginecol Obstet Mex 2021; 89 (01)

Hyperandrogenism in postmenopausal women: a case report

Mariño-Méndez H, González-Palanca SJ, Rodríguez-López JÁ, Palmeiro-Fernández G, Varela-Ponte C, Domínguez-Salgado JC

Language: Spanish
References: 24
Page: 51-57
PDF size: 229.57 Kb.


ABSTRACT

Background: Hyperandrogenism is a clinical picture characterized by excess production of androgens of ovarian or adrenal origin accompanied or not by clinical signs of female virilization. It is scarce in postmenopause and can be caused by benign pathologies or malignant tumors.
Clinical cases: A 64-year-old patient, with menarche at 12 years and menopause at 51, nulliparous. In treatment for mixed dyslipidemia and hypothyroidism after total thyroidectomy. She presented a characteristic clinical picture with increased terminal hair, lower voice, increased clitoris and libido. Normal hormonal profile except for testosterone above physiological levels for menopause. After performing the relevant studies, ovarian origin was suspected and a laparoscopic bilateral adnexectomy was scheduled. After surgery, the anatomical-pathological diagnosis of benign stromal hyperplasia was made, and the symptoms disappeared.
Conclusions: hyperandrogenism in the post menopause is infrequent and we must carry out an adequate anamnesis, exploration and clinical orientation for its study and typification. There are benign and malignant causes of ovarian and adrenal origin.


REFERENCES

  1. Guía de Asistencia Práctica de la Sociedad Española de Ginecología y Obstetricia. Estudio y tratamiento de los hiperandrogenismos. Prog Obstet Ginecol. 2017; 60 (6): 618-24.

  2. Usandizaga JA, et al. Obstetricia y Ginecología, volumen 2. 4ª ed. Barcelona: Marbán, 2018.

  3. Lambrinoudaki I, et al. A case of postmenopausal androgen excess. Gynecol Endocrinol. 2015; 31 (10): 760-4. doi. 10.3109/09513590.2015.1075500.

  4. Castelo-Branco C y Peralta S. Hiperandrogenismo ovárico. Valoración clínica y terapéutica. Clin Invest Gin Obst. 2005; 32 (6): 244-56. doi.10.106/S0210-573X(05)73503-6.

  5. Goldman JM, Kapadia L. Virilization in a postmenopausal woman due to ovarian stromal hyperthecosis. Postgrad Med J. 1991; 67: 304-6. doi.10.1136/pgmj.67.785.304.

  6. Czyzyk A, et al. Severe hyperandrogenemia in postmenopausal woman as a presentation of ovarian hyperthecosis. Case report and mini review of the literature. Gynecol Endocrinol. 2017; 33 (11): 836-39. doi.10.1080/0951359 0.2017.1337094.

  7. Damodaran S, et al. Ovarian Stromal Hyperplasia and Hyperthecosis: An Unusual Case of Post-Menopausal Hirsutism. Eur J Obstet Gynecol Reprod Biol. 2011; 158 (1): 114-5. doi. 10.1016/j.ejogrb.2011.04.014.

  8. Salman P et al. Hiperandrogenismo avanzado en una mujer postmenopáusica. Caso clínico. Rev Med Chile. 2011; 139: 1066-1070. doi.10.4067/S0034-98872011000800013.

  9. Arteaga E, et al. Postmenopausal androgen-secreting ovarian tumors: challenging differential diagnosis in two cases. Climacteric. 2019; 22 (4): 324-28. doi.10.1080/136 97137.2018.1549214.

  10. Chen M, et al. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report. Medicine (Baltimore). 2018; 97 (10): e0093. doi.10.1097/MD.0000000000010093.

  11. Hofland M, et al. Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases. Gynecol Endocrinol. 2013; 29 (3): 213-5. doi. 10.3109/09513590.2012.705375.

  12. Adefris M, Fekadu E. Postmenopausal mild hirsutism and hyperandrogenemia due to granulosa cell tumor of the ovary: a case report. J Med Case Rep. 2017; 11 (1): 242. doi. 10.1186/s13256-017-1411-3.

  13. Campos S, et al. Tumor de la granulosa de tipo adulto. Clin Invest Gin Obst. 2010;37(4):158-62. doi.10.1016/j. gine.2009.01.009.

  14. Mas S, et al. Virilizing ovarian tumors: a single center experience. Endocr Connect. 2018 Nov 1. pii: EC-18-0360. R1. doi: 10.1530/EC-18-0360.

  15. Correa BR, et al. Tumor de células de Sertoli y Leydig del ovario. Rev Chil Obstet Ginecol. 2003; 68 (5): 399-406. doi.10.4067/S0717-75262003000500008.

  16. Castro-Dufourney I, Saiz-Pardo-Sanz M. Hiperandrogenismo tras la menopausia. Rev Clin Esp. 2013; 213 (3): e19-e22. doi.10.1016/j.rce.2012.12.004.

  17. Leong S, Trivedi A. A case of ovarian stromal hyperplasia causing hirsutism in a postmenopausal woman. Aust N Z J Obstet Gynecol 2001; 41: 1: 102-3. doi.10.1111/j.1479- 828x.2001.tb01305.

  18. Fritz M, Speroff L. Endocrinología ginecológica clínica y esterilidad. 8° ed. Madrid: Lippincott Williams & Wilkins, 2011.

  19. Cook H, et al. Reanalyzing the modified Ferriman‐Gallwey score: is there a simpler method assessing the extent of hirsutism for? Fertility & Sterility 2011; 96 (5): 1266‐70. doi.10.1016/j.fertnstert.2011.08.022.

  20. Macut D, et al. Cardiovascular risk factors and events in women with androgen excess. J Endocrinol Invest. 2015; 38 (3): 295-301. doi. 10.1007/s40618-014-0215-1.

  21. Ajith S, et al. Postmenopausal hyperandrogenism of ovarian origin: A clinicopathologic study of five cases. J Midlife Health. 2016; 7 (4): 189-92. doi.10.4103/0976-7800.195699.

  22. Agarwal M, Trerotola S. Combined adrenal and ovarian venous sampling to localize an androgen producing tumor. Cardiovasc Intervent Radiol. 2010; 33: 1266-1269. doi. 10.1007/s00270-009-9689-1.

  23. Mamoojee Y, et al. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis. Clin Endocrinol (Oxf). 2018; 88 (1): 13-20. doi. 10.1111/cen.13492.

  24. Lee WL, et al. Managing a patient with presumed testosterone secreting ovarian tumour. Gynecol Oncol 1999; 75: 175-77. doi. 10.1006/gyno.1999.5507.




2020     |     www.medigraphic.com